Non-biological complex drugs (NBCDs) and their follow-on versions: time for an editorial section

Non-biological complex drugs (NBCDs) and their follow-on versions: time for an editorial section

This paper discusses the group of non-biological complex drug (NBCD) products and presents the reasons why NBCDs should be assigned a special position in our arsenal of medicines as well as why from now on a special section will be devoted to report on these NBCD products in the GaBI Journal. Keywor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:GaBI Journal 2015-12, Vol.4 (4), p.167-170
Hauptverfasser: de Vlieger, Jon S.B, Muhlebach, Stefan, Shah, Vinod P, McNeil, Scott E, Borchard, Gerrit, Weinstein, Vera, Fluhmann, Beat, Neervannan, Sesha, Crommelin, Daan J.A
Format: Artikel
Sprache:eng
Schlagworte:
Drugs
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This paper discusses the group of non-biological complex drug (NBCD) products and presents the reasons why NBCDs should be assigned a special position in our arsenal of medicines as well as why from now on a special section will be devoted to report on these NBCD products in the GaBI Journal. Keywords: Glatiramoids, iron-carbohydrate complexes, liposomes, nanomedicines, Non-Biological Complex Drug (NBCD) products, therapeutic equivalence
ISSN:2033-6403
2033-6772
DOI:10.5639/gabij.2015.0404.037